# EDGAR Filing Document

**Accession Number:** 0002035992
**File Stem:** 0001213900-25-109508
**Filing Date:** 2025-11
**Character Count:** 3691
**Document Hash:** 7fc136fc5a0a94c1e6cc02efd1b6826a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-109508.hdr.sgml**: 20251113

**ACCESSION NUMBER**: 0001213900-25-109508

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251113

**FILED AS OF DATE**: 20251113

**DATE AS OF CHANGE**: 20251113

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Charming Medical Ltd
- **CENTRAL INDEX KEY:** 0002035992
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42907
- **FILM NUMBER:** 251475170

**BUSINESS ADDRESS:**
- **STREET 1:** UNITS 1803-1U806, 18/F, HANG LUNG CENTRE
- **STREET 2:** 2-20 PATERSON STREET, CAUSEWAY BAY
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 00000
- **BUSINESS PHONE:** 852 2116 1492

**MAIL ADDRESS:**
- **STREET 1:** UNITS 1803-1U806, 18/F, HANG LUNG CENTRE
- **STREET 2:** 2-20 PATERSON STREET, CAUSEWAY BAY
- **CITY:** HONG KONG
- **STATE:** K3
- **ZIP:** 00000

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of November 2025**

**Commission File Number: 001-42907**

**Charming Medical Limited**

**Units 1803-1806, 18/F, Hang Lung Centre<br> 2-20 Paterson Street, Causeway Bay, Hong Kong**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

**Temporary Suspension of Trading**

On November 11, 2025, Charming Medical Limited (the "Company") received from the U.S. Securities and Exchange Commission (the "SEC") an order (the "Order") suspending trading in the Company's securities for the period from 4:00 AM ET on November 12, 2025, through 11:59 PM ET on November 25, 2025. The Order is available at *https://www.sec.gov/files/litigation/suspensions/2025/34-104176-ts.pdf*. According to the Order, the suspension was imposed due to potential manipulation in the trading of the Company's securities that may have been effectuated through recommendations made to investors by unknown persons via social media to purchase, hold, and/or sell the Company's securities and to post screenshots of their transactions. The SEC stated that such activities appeared to be designed to artificially influence the market price and trading volume of the Company's securities. On November 12, 2025, the Company received an information request from The Nasdaq Stock Market LLC ("Nasdaq") for certain information and documents.

The Company has not authorized, participated in, or been involved with any promotion or recommendation of its securities via social media or otherwise. It is fully committed to cooperating fully with the SEC, Nasdaq, and other regulatory authorities as necessary. The Company's ongoing business operations remain normal, and there has been no material change to the Company's business operations or financial position as of the date of this report.

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Charming Medical Limited** | **Charming Medical Limited** |
| Date: November 13, 2025 | By: | */s/ Kit Wong* |
|  | Name: | Kit Wong |
|  | Title: | Chief Executive Officer and Chairman of the Board |

---